Research Pipeline
From raw tumor DNA to mRNA vaccine candidate — 5 autonomous steps powered by AI agents.
1
Mutation Discovery
Mutation HunterScans tumor genomes from TCGA using ensemble variant calling (Mutect2 + Strelka2 + VarScan2) to identify somatic mutations.
2
Neoantigen Screening
Neoantigen ScoutPredicts which mutations produce neoantigens visible to the immune system using peptide-MHC binding prediction.
3
Protein Structure
Structure ProphetPredicts 3D structures of neoantigen peptide-MHC complexes to validate binding stability.
4
mRNA Vaccine Design
mRNA ArchitectDesigns optimized mRNA sequences encoding selected neoantigens with maximum stability and immunogenicity.
5
Drug Simulation
Drug SimulatorValidates vaccine candidates through molecular docking and binding affinity simulations.